Alex W. Tong - Dallas TX, US Yu Yang - Allen TX, US Donald Rao - Dallas TX, US Phillip B. Maples - Pilot Point TX, US Neil Senzer - Dallas TX, US John J. Nemunaitis - Cedar Hill TX, US Zhaohui Wang - Grapevine TX, US
Compositions and methods of augmenting the anti-tumor activities of docetaxel and other taxanes by combination with a bi-functional small hairpin RNA (bi-shRNA) is described herein. The instant invention describes the interactive outcome of STMN1 knockdown with docetaxel. In vitro docetaxel (DOC) dose response assessments with or without co-treatment with bi-shRNAin CCL-247 and SK-MEL-28 melanoma cells indicated that STMN1 knockdown significantly reduced DOC concentration needed to inhibit cancer cell growth by 50% (IC) of CCL-247 cells from 1.80.2 to 0.60.4 nm (n=3, p